DrugPatentWatch Database Preview
Drugs in Development Information for Varespladib methyl
What is the drug development status for Varespladib methyl?
Varespladib methyl is an investigational drug.
There have been 4 clinical trials for Varespladib methyl.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Acute Coronary Syndrome, and Renal Insufficiency. The leading clinical trial sponsors are Anthera Pharmaceuticals and [disabled in preview].
There are thirty-nine US patents protecting this investigational drug and two hundred and ninety-five international patents.
Summary for Varespladib methyl
| US Patents | 39 |
| International Patents | 295 |
| US Patent Applications | 40 |
| WIPO Patent Applications | 50 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2010-05-01) |
| Vendors | 11 |
Recent Clinical Trials for Varespladib methyl
| Title | Sponsor | Phase |
|---|---|---|
| A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function | Anthera Pharmaceuticals | Phase 1 |
| Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects | Anthera Pharmaceuticals | Phase 1 |
| VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome | Anthera Pharmaceuticals | Phase 3 |
Clinical Trial Summary for Varespladib methyl
Top disease conditions for Varespladib methyl
Top clinical trial sponsors for Varespladib methyl
US Patents for Varespladib methyl
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Varespladib methyl | Start Trial | 1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| Varespladib methyl | Start Trial | 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| Varespladib methyl | Start Trial | 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| Varespladib methyl | Start Trial | Process for preparing 1H-indole-3-glyoxylamides | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| Varespladib methyl | Start Trial | Method for treatment of chronic bronchitis using indole compounds | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Varespladib methyl
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Varespladib methyl | Austria | 220394 | 2014-04-01 | Start Trial |
| Varespladib methyl | Austria | 540923 | 2014-04-01 | Start Trial |
| Varespladib methyl | Australia | 1621795 | 2014-04-01 | Start Trial |
| Varespladib methyl | Australia | 688458 | 2014-04-01 | Start Trial |
| Varespladib methyl | Brazil | 9501404 | 2014-04-01 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
